
Anti-inflammatory tripeptide for gut, skin, and immune support.
KPV is a tripeptide derived from the C-terminus of α-MSH, well-studied for its anti-inflammatory effects in mucosal tissue, the gut, and the skin.
Modulates NF-κB inflammatory signaling and supports gut barrier and skin barrier integrity, with broad immune-modulating effects.
Typical research protocol: 250–500 mcg daily, subcutaneous or oral.
For laboratory and research use only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. All protocols are reference summaries provided for educational purposes — always consult a qualified healthcare professional.